ATE506053T1 - Zusammensetzung aus liponsäure-pellets - Google Patents

Zusammensetzung aus liponsäure-pellets

Info

Publication number
ATE506053T1
ATE506053T1 AT08840866T AT08840866T ATE506053T1 AT E506053 T1 ATE506053 T1 AT E506053T1 AT 08840866 T AT08840866 T AT 08840866T AT 08840866 T AT08840866 T AT 08840866T AT E506053 T1 ATE506053 T1 AT E506053T1
Authority
AT
Austria
Prior art keywords
composition
acid pellets
liponic acid
pellets
liponic
Prior art date
Application number
AT08840866T
Other languages
English (en)
Inventor
Paolo Magri
Antonio Nardi
Annibale Salvi
Flavio Villani
Original Assignee
Laboratorio Chimico Int Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Chimico Int Spa filed Critical Laboratorio Chimico Int Spa
Application granted granted Critical
Publication of ATE506053T1 publication Critical patent/ATE506053T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicinal Preparation (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Fats And Perfumes (AREA)
AT08840866T 2007-10-23 2008-10-23 Zusammensetzung aus liponsäure-pellets ATE506053T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002051A ITMI20072051A1 (it) 2007-10-23 2007-10-23 Composizione a base di pellet di acido lipoico
PCT/IB2008/002835 WO2009053824A1 (en) 2007-10-23 2008-10-23 Lipoic acid pellet composition

Publications (1)

Publication Number Publication Date
ATE506053T1 true ATE506053T1 (de) 2011-05-15

Family

ID=40313864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08840866T ATE506053T1 (de) 2007-10-23 2008-10-23 Zusammensetzung aus liponsäure-pellets

Country Status (27)

Country Link
US (1) US9820948B2 (de)
EP (1) EP2217220B1 (de)
JP (1) JP5626890B2 (de)
KR (1) KR101599078B1 (de)
CN (1) CN101861144B (de)
AT (1) ATE506053T1 (de)
AU (1) AU2008315667B2 (de)
BR (1) BRPI0816587A2 (de)
CA (1) CA2703152C (de)
CY (1) CY1112122T1 (de)
DE (1) DE602008006454D1 (de)
DK (1) DK2217220T3 (de)
ES (1) ES2363880T3 (de)
HR (1) HRP20110453T1 (de)
IL (1) IL205211A (de)
IT (1) ITMI20072051A1 (de)
MX (1) MX2010004481A (de)
NZ (1) NZ584884A (de)
PL (1) PL2217220T3 (de)
PT (1) PT2217220E (de)
RS (1) RS51712B (de)
RU (1) RU2501558C2 (de)
SI (1) SI2217220T1 (de)
TN (1) TN2010000163A1 (de)
UA (1) UA100394C2 (de)
WO (1) WO2009053824A1 (de)
ZA (1) ZA201002777B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
WO2011099031A1 (en) 2010-02-11 2011-08-18 Zota Health Care Limited Active antioxidants for all age group
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20130045273A1 (en) * 2011-08-19 2013-02-21 John Cuomo Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds
CA2965671A1 (en) * 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
US20200101043A1 (en) * 2016-12-14 2020-04-02 Cidat, S.A. De C.V. Combinations and methods for the treatment of neuropathic pain
CN106729725A (zh) * 2017-03-21 2017-05-31 北京百慧生化制药有限责任公司 硫辛酸作为抗氧化剂在多烯酸乙酯制剂或蛹油α‑亚麻酸乙酯制剂中的应用
IT202200007232A1 (it) * 2022-04-12 2023-10-12 Uriach Italy S R L Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche
WO2023199241A1 (en) * 2022-04-12 2023-10-19 URIACH ITALY S.r.l. Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0774166B2 (ja) * 1987-02-06 1995-08-09 信越化学工業株式会社 徐放性被覆薬剤の製造方法
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
AU2002230543A1 (en) * 2000-11-02 2002-05-15 Nutrition 21, Inc. Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
ITMI20012732A1 (it) * 2001-12-20 2003-06-20 Health Pharma S R L Integratore alimentare per neuropatici
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
CN1694695A (zh) * 2002-11-07 2005-11-09 帝斯曼知识产权资产管理有限公司 包含表没食子儿茶素没食子酸酯的新颖的营养药物性组合物
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US20060182729A1 (en) * 2005-02-17 2006-08-17 Prasad Kedar N Combat/training antioxidant micronutrient formulation and method of administration
JP2006298831A (ja) * 2005-04-21 2006-11-02 Sumitomo Shoji Chemicals Co Ltd αリポ酸粉体被覆物及びその製造方法、並びにαリポ酸含有食品
JP5157001B2 (ja) * 2005-04-30 2013-03-06 ビーエイチエヌ株式会社 安定化α−リポ酸組成物及びその利用
US20060270625A1 (en) * 2005-05-13 2006-11-30 Eastern Virginia Medical School Nutraceuticals for the treatment of neuropathy
JP5085329B2 (ja) * 2005-09-12 2012-11-28 協和発酵バイオ株式会社 α−リポ酸含有組成物
US20100239549A1 (en) * 2006-04-26 2010-09-23 Dpi Solutions, Inc. Alpha lipoic acid capsule composition stabilized in water phase and method for preparing the same
ITMI20061024A1 (it) * 2006-05-25 2007-11-26 Eurand Pharmaceuticals Ltd Pellet a base di acido lipoico

Also Published As

Publication number Publication date
TN2010000163A1 (en) 2011-11-11
US20110129442A1 (en) 2011-06-02
ITMI20072051A1 (it) 2009-04-24
JP5626890B2 (ja) 2014-11-19
CN101861144B (zh) 2013-03-13
RS51712B (en) 2011-10-31
US9820948B2 (en) 2017-11-21
AU2008315667A1 (en) 2009-04-30
ZA201002777B (en) 2011-06-29
CY1112122T1 (el) 2015-11-04
AU2008315667B2 (en) 2013-02-28
CA2703152A1 (en) 2009-04-30
RU2501558C2 (ru) 2013-12-20
EP2217220B1 (de) 2011-04-20
DK2217220T3 (da) 2011-08-01
NZ584884A (en) 2011-11-25
CA2703152C (en) 2016-02-23
IL205211A (en) 2013-01-31
EP2217220A1 (de) 2010-08-18
JP2011500784A (ja) 2011-01-06
SI2217220T1 (sl) 2011-06-30
HRP20110453T1 (hr) 2011-07-31
IL205211A0 (en) 2010-12-30
DE602008006454D1 (de) 2011-06-01
WO2009053824A1 (en) 2009-04-30
MX2010004481A (es) 2010-08-02
ES2363880T3 (es) 2011-08-18
UA100394C2 (en) 2012-12-25
KR20100089848A (ko) 2010-08-12
KR101599078B1 (ko) 2016-03-02
PL2217220T3 (pl) 2011-09-30
CN101861144A (zh) 2010-10-13
BRPI0816587A2 (pt) 2015-03-03
PT2217220E (pt) 2011-07-13
RU2010120706A (ru) 2011-11-27

Similar Documents

Publication Publication Date Title
ATE506053T1 (de) Zusammensetzung aus liponsäure-pellets
BRPI0814031A2 (pt) Composições antimicrobianas de ácido peroxicarboxílico prontas para o uso, com corrosão reduzida, estáveis em prateleira.
TR201907828T4 (tr) Geni̇ş spektrumlu bi̇r anti̇-mi̇krobi̇yel ajan
MY158503A (en) Use of peptides for imparting kokumi
RS53312B (en) TERNARY HERBICIDE COMPOSITIONS CONTAINING AMINOPYRALID AND IMAZAMOX
WO2009077471A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
ATE555156T1 (de) Sauerstofffänger-mischungen
IN2012DN01418A (de)
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
UY32187A (es) Composiciones farmaceuticas topicas
GT200600121A (es) Novedosos derivados de triazolopirimidina
AR067018A1 (es) Inhalador
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
ATE510900T1 (de) Reversible thermochrome zusammensetzungen
DK2478054T3 (da) Polyamidsammensætning, som indeholder polyamid 4,10
CR20120521A (es) Combinaciones de principios activos
DK2219662T3 (da) Aktive, opløselige, post-translationelt modificerede neuregulin- isoformer.
CR8537A (es) Moduladores de HM74 de Oxidecahidronaftaleno
MX2010006509A (es) Formulaciones herbicidas para sales de trietanolamina de glifosato.
FR2908300B1 (fr) Composition cosmetique comprenant un acide gras en c16-c-30 et un acide basique, procedes et utilisations.
ATE537816T1 (de) Leflunomid enthaltende pharmazeutische zusammensetzungen
TR201005327A2 (tr) Sinerjik farmasötik formülasyonlar.
TW200708571A (en) Acid dye composition
DK2044853T3 (da) Næringsstof til anvendelse til accelereret fysiologisk præstationsforbedring
장수형 42page 70page

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2217220

Country of ref document: EP